ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's drug aims to clear brain plaques
Disease control OngoingThis study tests an experimental drug called RO7126209 (Trontinemab) in people with early to moderate Alzheimer's disease. The drug is given by IV infusion and aims to reduce amyloid plaques in the brain, a hallmark of Alzheimer's. About 241 participants will receive either the d…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can new drugs delay inherited Alzheimer's? major trial underway
Disease control OngoingThis study tests whether experimental drugs can slow down memory and thinking problems in people who have a gene mutation that causes Alzheimer's disease. About 490 adults aged 18-80 with this genetic risk are taking either a study drug or a placebo. The goal is to see if the dru…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to halt Alzheimer's in people with genetic mutation
Disease control OngoingThis study tests whether two drugs, E2814 and lecanemab, can slow the progression of Alzheimer's in people who carry a gene mutation that causes the disease. About 197 participants will receive either the drugs or a placebo over 2 to 4 years. Researchers will measure changes in t…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gum treatment may help fight Alzheimer's, small trial hints
Disease control ENROLLING_BY_INVITATIONThis study tests whether treating severe gum disease can slow down Alzheimer's disease. Researchers will give 26 people with both conditions deep dental cleaning, extractions if needed, and oral hygiene training. Over 24 months, they will track memory, thinking skills, and brain …
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Blood test aimed to speed up Alzheimer's diagnosis, but study was canceled
Knowledge-focused TerminatedThis study planned to see if using a special blood test (PrecivityAD2) could help doctors diagnose Alzheimer's disease or other dementias more quickly. It was designed for veterans and people in other closed healthcare systems who had memory problems. However, the study was withd…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC